NETWORK PHARMACOLOGY AND MOLECULAR DOCKING-BASED PREDICTIONS OF PHARMACOLOGICAL EFFECTS OF FERULIC ACID

LIZA K PATEL

doi:10.22159/ijms.2023.v11i3.47982

Authors

LIZA K PATEL Department of Bioinformatics, Guru Nanak College of Arts Science and Commerce (Autonomous), Matunga, Mumbai, Maharashtra, India.

DOI:

https://doi.org/10.22159/ijms.2023.v11i3.47982

Keywords:

Network pharmacology, Molecular Docking, Ferulic acid, ADMET, Cancer, Neurological disorders

Abstract

Objectives: The main objective of this study is to reveal new possible pharmacological effects of ferulic acid. This is achieved by network pharmacology by discovering potential target genes for ferulic acid, along with constructing a PPI network for those targets and performing gene enrichment analysis to understand possible diseases or disorders being affected due to the target genes. The study involves the molecular docking of target genes with ferulic acid to understand the interactions between them.

Methods: ADMETlab 2.0 was used for the pharmacokinetics study of ferulic acid. Using SwissTargetPrediction and STITCH database 79 target genes were retrieved which were used to construct a PPI network using the STRING database and for gene enrichment analysis using the ShinyGo tool. Analyzing the clusters generated by k-means clustering in the STRING database, three target gene proteins were further used to perform molecular docking with ferulic acid using PyRx software, and 2D and 3D visualization was done using Biovia Discovery Studio Visualizer.

Results: The ADMET analysis ferulic acid showed drug-likeliness. SwissTargetPrediction and STITCH database revealed 79 potential target genes. Three proteins (RELA, ALOX15, and STAT3) were selected from the PPI network analysis using the STRING database for molecular docking and visualization. ALOX15 showed the least binding energy among all three target proteins. Gene enrichment analysis suggests the target proteins are involved in cancer, neurological disorders, psychiatric disorders, Alzheimer’s disease, etc.

Conclusion: The findings of this research suggest that ferulic acid may have a wide range of pharmacological effects and gives a new perspective on its application in the field of drug discovery.

References

Al Jitan S, Alkhoori SA, Yousef LF. Phenolic acids from plants: Extraction and application to human health. Stud Nat Prod Chem 2018;58:389-417.

Saxena M, Saxena J, Nema R, Singh D, Gupta A. Phytochemistry of medicinal plants. J Pharmacogn Phytochem 2013;1:168-82.

Kumar N, Goel N. Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol Rep (Amst) 2019;24:e00370.

Warren B. Uses and potential applications of Ferulic acid. In: Ferulic acid: Antioxidant Properties, Uses and Potential Health Benefits. United States: Nova Publishers; 2015. p. 39-70.

Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: Therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007;40:92-100.

Kumar N, Pruthi V. Potential applications of ferulic acid from natural sources. Biotechnol Rep (Amst) 2014;4:86-93.

Chandran U, Mehendale N, Patil S, Chaguturu R, Patwardhan B. Network pharmacology. In: Innovative Approaches in Drug Discovery. Amsterdam: Elsevier; 2017. p. 127-64.

Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res 2015;44:D1202-13.

Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021;49:W5-14.

Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res 2014;42:W32-8.

Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. Stitch: Interaction networks of chemicals and proteins. Nucleic Acids Res 2007;36:D684-8.

Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The string database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 2020;49:D605-12.

Ge SX, Jung D, Yao R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 2019;36:2628-9.

Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28:235-42.

Dassault Systèmes. Biovia Discovery Studio Visualizer. France: Dassault Systèmes; 2020. Available from: https://discover.3ds.com/ discovery-studio-visualizer-download [Last accessed on 2023 Mar 03].

Acknowledgment. Welcome to the PyRx Website. (n.d.). Available from: https://pyrx.sourceforge.io/[Last accessed on 2023 Mar 03].

Hopkins AL. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol 2008;4:682-90.

Guan L, Yang H, Cai Y, Sun L, Di P, Li W, et al. ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm 2019;10:148-57.

Explanation. ADMETlab 2.0. (n.d.). Available from: https://admetmesh. scbdd.com/explanation/index [Last accessed on 2023 Mar 04].

Zhang Z, Xiahou Z, Wu W, Song Y. Nitrogen metabolism disorder accelerates occurrence and development of lung adenocarcinoma: A bioinformatic analysis and in vitro experiments. Front Oncol 2022;12:916777.

Li D, Yu S, Long Y, Shi A, Deng J, Ma Y, et al. Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. Front Immunol 2022;13:985378.

Wang T, Eskandari D, Zou D, Grote L, Hedner J. Increased carbonic anhydrase activity is associated with sleep apnea severity and related hypoxemia. Sleep 2015;38:1067-73.

Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, et al. Estrogen metabolism and risk of breast cancer: A prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-40.

Newman AC, Maddocks OD. One-carbon metabolism in cancer. Br J Cancer 2017;116:1499-504.

Alka K, Casey JR. Bicarbonate transport in health and disease. IUBMB Life 2014;66:596-615.

Salih DA, Bayram S, Guelfi S, Reynolds RH, Shoai M, Ryten M, et al. Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk. Brain Commun 2019;1:fcz022.

U.S. National Library of Medicine. (n.d.). Alox15 Arachidonate 15-lipoxygenase [Homo Sapiens (Human)]-gene. National Center for Biotechnology Information. Available from: https://www.ncbi.nlm.nih. gov/gene/246 [Last accessed on 2023 Mar 05].

Singh NK, Rao GN. Emerging role of 12/15-lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res 2019;73:28-45.